No Matches Found
No Matches Found
No Matches Found
Bilcare Surges with Unprecedented Buying Interest, Poised for Multi-Day Upper Circuit
Bilcare Ltd has witnessed extraordinary buying momentum, registering a near 10% gain in a single session with no sellers in the queue, signalling a potential multi-day upper circuit scenario. This surge stands in stark contrast to the broader market’s modest gains, underscoring a remarkable investor appetite for the healthcare services stock.
Why is Bilcare falling/rising?
On 21-Nov, Bilcare Ltd’s stock price fell sharply by 4.04% to close at ₹78.35, reflecting a significant short-term weakness despite its strong long-term performance relative to the benchmark Sensex.
Why is Bilcare falling/rising?
As of 18-Nov, Bilcare Ltd's stock price is Rs 83.35, down 5.45% and has lost 18.32% over the last six days. Despite a year-to-date gain of 27.12%, recent performance has been poor compared to the Sensex, indicating a negative shift in investor sentiment.
Bilcare Faces Financial Struggles Despite Strong Liquidity Position and Long-Term Resilience
Bilcare, a microcap in healthcare services, has faced significant financial challenges for the quarter ending September 2025, with a notable decline in key performance metrics. Despite achieving a high liquidity position, the company reported a substantial loss in profit after tax and low net sales, indicating operational difficulties.
How has been the historical performance of Bilcare?
Bilcare's historical performance has been volatile, with net sales declining from 2,997.01 Cr in Mar'19 to 788.04 Cr in Mar'25, and significant losses in profit before tax and profit after tax in recent years. However, there are signs of recovery in cash flow, which turned positive at 84.00 Cr in Mar'25.
How has been the historical performance of Bilcare?
Bilcare's historical performance has been marked by declining net sales and profitability, with net sales dropping from 2,997.01 Cr in Mar'19 to 788.04 Cr in Mar'25, and a negative profit before tax of -71.34 Cr in Mar'25. Despite some recovery in cash flow from operations, the company continues to face significant financial challenges.
Are Bilcare latest results good or bad?
Bilcare's latest results are concerning, with net sales at Rs 186.36 crore, the lowest in five quarters, and a significant decline in net profit of -135.32% compared to the previous quarter, indicating ongoing operational challenges.
When is the next results date for Bilcare?
The next results date for Bilcare is 14 November 2025.
Why is Bilcare falling/rising?
As of 06-Nov, Bilcare Ltd's stock price is at 100.00, down 4.26% today and underperforming its sector. Despite strong long-term returns, recent performance shows a significant decline in delivery volume and a lag behind the broader market.
Bilcare Hits New 52-Week High of Rs. 116, Surges 20.38% in Four Days
Bilcare, a microcap healthcare services company, achieved a new 52-week high of Rs. 116 on October 27, 2025, reflecting strong stock performance. Over the past four days, it gained 20.38%, significantly outperforming its sector and demonstrating a robust upward trend in its one-year performance.
Why is Bilcare falling/rising?
As of 24-Oct, Bilcare Ltd's stock price is at 108.12, up 7.61%, with a recent 52-week high of Rs. 110.51 and strong momentum reflected in a 19.4% gain over three days. Despite impressive returns, a 39.15% drop in delivery volume suggests cautious investor sentiment amidst the stock's outperformance.
Bilcare Hits New 52-Week High of Rs. 110.51, Outperforming Sector
Bilcare, a microcap healthcare services company, achieved a new 52-week high of Rs. 110.51 on October 24, 2025, reflecting a strong upward trend with a 20.38% return over three days. The stock is trading above key moving averages, showcasing its robust market position amid broader market fluctuations.
Why is Bilcare falling/rising?
As of 23-Oct, Bilcare Ltd's stock price is at 100.00, having recently reached a 52-week high and showing a total return of 10.44% over the last two days. The stock has significantly outperformed the market with a year-to-date return of 52.51%, indicating strong investor interest and positive momentum.
Bilcare Hits New 52-Week High of Rs. 103.99, Showcasing Strong Market Performance
Bilcare, a microcap healthcare services company, achieved a new 52-week high of Rs. 103.99 on October 23, 2025, following a notable upward trend. The stock has outperformed its sector over the past year, while the broader market, including the Sensex, also reached new highs, indicating overall positive momentum.
Bilcare Hits New 52-Week High of Rs. 101.5, Outperforming Sector
Bilcare, a microcap in healthcare services, achieved a new 52-week high of Rs. 101.5 on October 16, 2025, outperforming its sector. The stock has gained 14.15% over two days and is trading above key moving averages, reflecting strong market sentiment amid broader positive trends in the small-cap sector.
Bilcare Ltd Surges 10% Today, Achieves 50.30% Annual Gain Amid Strong Buying Activity
Bilcare Ltd, a microcap in healthcare services, is experiencing notable buying activity, with a significant stock increase today after three days of declines. Over the past week and year, it has outperformed the Sensex, indicating strong momentum and positive market dynamics influencing its performance.
Why is Bilcare falling/rising?
As of 09-Oct, Bilcare Ltd's stock price is rising to Rs 91.93, reflecting a 9.99% increase. Despite strong performance and significant returns over the past year, a decline in delivery volume raises concerns about sustained investor interest.
Bilcare Ltd Surges 9.99% Today, Achieves 40.20% Year-to-Date Gain Amid Strong Buying Activity
Bilcare Ltd, a microcap in healthcare services, is experiencing notable buying activity, with significant stock gains today and over the past week. The stock has shown consistent growth over three months and the past year, outperforming the Sensex, driven by positive market sentiment and strong performance metrics.
Why is Bilcare falling/rising?
As of 30-Sep, Bilcare Ltd's stock price is Rs 82.39, down 3.15% and showing a 9.78% decline over the past five days. Despite strong long-term performance, recent volatility and decreased trading volume indicate negative short-term sentiment.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
